FDA Device Intelligence
HomePAN-AMERICA HYPERBARICS INC. › PAHI PAH-S1 Monoplace Hyperbaric Chamber

PAHI PAH-S1 Monoplace Hyperbaric Chamber

PAN-AMERICA HYPERBARICS INC. · Model PAH-S1 · UDI-DI 04719872000013

CBF Prescription
1
510(k) clearances
153
Adverse events (12 deaths)
3
Recalls
18
Facilities

Description

The PAH-SI Hyperbaric Chamber System is a Class B monoplace hyperbaric chamber designed to treat one patient at up to a maximum operating pressure of 3 Atmospheres Absolute (ATA) or 29.4 pounds per square inch gauge (psig). The chamber uses 100% oxygen as the pressurization gas and patient breathes the oxygen contained inside the chamber as the hyperbaric treatment gas.

Recalls

DateFirmReason
2014-08-08Baro-Therapies, IncThe firm is distributing the Rejuvenator device without an approved 510(k).
2008-08-28Sechrist Industries IncSechrist conducted a field upgrade on the hyperbaulic chambers equipped with Electronic Control Modules in order to correct a software bug that could potentially affect the perform
2008-08-28Sechrist Industries IncSechrist conducted a field upgrade on the hyperbaulic chambers equipped with Electronic Control Modules in order to correct a software bug that could potentially affect the perform

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.